The genomics revolution has brought personalised medicine to cancer and rare diseases, but cardiovascular care is stuck in the past. An EU-funded initiative aims to change that
The Paediatric Regulation has “basically forced” companies to tailor drugs for use by children, but more work is needed to plug gaps in the area of childhood rare diseases
Plan for the last three years of the EU R&D programme sees a tighter focus, more funding for research on security and migration, money for foreign researchers and a pledge to do more to help poorer member states develop their science base
‘Focus areas’, ‘lump-sum’ payments and studies into migration, extremism and blockchain among novelties in 3-year plan. But who will run ‘Agency for Disruptive Innovation?’
Fears that the EU will give up its involvement in health won’t go away. A big concern is that the next president of the Commission “might abolish” its responsibilities, says Austria’s director-general for health
‘Keep collaborating,’ EU commissioner tells UK grantees rattled by legal uncertainties over Brexit, while UK science minister argues that government pledge to underwrite funding has steadied UK involvement in EU science
Estonian Presidency of the EU has published a ‘Call for Action’ for more investment, bigger impact and more trust in science in the next EU research programme
Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.